COMMUNIQUÉS West-GlobeNewswire

VistaGen Therapeutics Receives AV-101 Japanese Patent for Treatment of Depression and Hyperalgesia
19/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central [...]
Assertio Therapeutics Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting Cosyntropin
19/02/2019
Company Anticipates Potential Market Launch by Early 2020 LAKE FOREST, Ill., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that it has received notification of acceptance [...]
Nuvectra to Report Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019
19/02/2019
PLANO, Texas, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the fourth quarter and full [...]
Cerecor Receives Fast Track Designation from FDA for CERC-801 for the Treatment of PGM1 Deficiency
19/02/2019
ROCKVILLE, Md., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
MediPharm Labs Announces Listing on Frankfurt Stock Exchange
19/02/2019
TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm”) a leader in specialized, research-driven cannabis extraction, distillation, purification and [...]
BrainStorm Issues a Statement to Patients and Shareholders
19/02/2019
NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, in [...]
Cognition Therapeutics Announces Publication of Complete Results from Phase 1 Clinical Trial of Elayta™
19/02/2019
Elayta Crossed Blood Brain Barrier and Reached CNS Levels Associated in Preclinical Studies with Cognitive Improvement Pittsburgh, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage [...]
Cabaletta Bio Appoints Experienced Financial Executive, Richard Henriques, to its Board of Directors
19/02/2019
RADNOR, Pa., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc., a biotechnology company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases, announced today the [...]
Voyager Therapeutics to Present at Upcoming Investor Conferences
19/02/2019
CAMBRIDGE, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]
GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease
19/02/2019
—The Access to Excellent Care for Sickle Cell Patients Pilot Program (ACCEL) Supports Novel Projects Aimed at Improving Access to High-Quality Healthcare for People with Sickle Cell Disease— —GBT Will Fund Proposals [...]
Imagin Medical to Report First Fiscal Quarter 2019 Financial Results on February 27, 2019 – Conference Call to Follow
19/02/2019
VANCOUVER, British Columbia and BOSTON, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in the [...]
VBL Therapeutics to Present Data on its Novel VB-600 Platform at Keystone Conference on February 26
19/02/2019
TEL AVIV, Israel, Feb. 19, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), today announces that the Company will present new data on the potential of its VB-600 platform targeting MOSPD2 for inflammatory and [...]
Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercialization Partnership
19/02/2019
NORTH BRUNSWICK, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) announced today that it has entered into an agreement with Oakrum Pharma, LLC (Oakrum) to develop and manufacture four [...]
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
19/02/2019
Diversifies Seelos’ pipeline in rare diseases Collaborates with Team Sanfilippo Foundation in development of Trehalose in Sanfilippo syndrome NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq [...]
Dova Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference
19/02/2019
DURHAM, N.C., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Dr. David Zaccardelli, President and Chief Executive Officer, will present a company overview at the 8 th [...]
Assertio Therapeutics Announces Appointment of Heather L. Mason to Board of Directors
19/02/2019
LAKE FOREST, Ill., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that Heather L. Mason has been appointed to the Company’s Board of Directors. Ms. Mason is a former [...]
Rexahn Presents Updated Interim Data From Phase 2a Trial of RX-3117 in Advanced Bladder Cancer at the 2019 ASCO GU Symposium
19/02/2019
Encouraging Preliminary Signs of Efficacy, Including One Complete Response, Observed in Patients With Advanced Bladder Cancer Who Have Progressed on Multiple Prior Treatments Including Immunotherapy and Gemcitabine [...]
AMAG Pharmaceuticals to Present at Leerink Partners Global Healthcare Conference
19/02/2019
WALTHAM, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will present at the Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019. Ted Myles, chief financial [...]
Spectral Announces Approval of Tigris Trial by the US FDA
19/02/2019
TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]

Pages